Progress achieved in maternal health-related parameters
| Parameter | L1 facilities (n=556) | L2 facilities (n=1354) | L3 facilities (n=438) | ||||||
| First visit (baseline) | Last visit | Progress in % points | First visit (baseline) | Last visit | Progress in % points | First visit (baseline) | Last visit | Progress in % points | |
| Availability of essential medicines and commodities (Source: observation and record review by monitor) | |||||||||
| Oxytocin (injectable) | 59% | 75% | ↑ 16 | 82% | 93% | ↑ 11 | 90% | 98% | ↑ 8 |
| Magnesium sulfate (injectable) | 39% | 54% | ↑ 15 | 73% | 86% | ↑ 13 | 88% | 93% | ↑ 5 |
| Antihypertensive drugs | 30% | 44% | ↑ 14 | 69% | 84% | ↑ 15 | 83% | 94% | ↑ 11 |
| Misoprostol (oral) | 52% | 70% | ↑ 18 | 70% | 79% | ↑ 9 | 82% | 92% | ↑ 10 |
| Pregnancy testing kits | 72% | 83% | ↑ 11 | 69% | 79% | ↑ 10 | 69% | 83% | ↑ 14 |
| Partographs | 40% | 64% | ↑ 24 | 62% | 79% | ↑ 17 | 68% | 83% | ↑ 15 |
| Protocol display in labour rooms | 44% | 60% | ↑ 16 | 70% | 85% | ↑ 15 | 74% | 92% | ↑ 18 |
| Practices in the labour room (Source: observations and record review by monitor) | |||||||||
| Recording fetal heart rate at time of admission | 49% | 60% | ↑ 11 | 72% | 80% | ↑ 8 | 83% | 90% | ↑ 7 |
| Using partograph to monitor labour | 31% | 48% | ↑ 17 | 52% | 66% | ↑ 14 | 57% | 72% | ↑ 15 |
| Administering uterotonic after birth | 75% | 84% | ↑ 9 | 91% | 93% | ↑ 2 | 97% | 98% | ↑ 1 |
| Using magnesium sulfate to manage pre-eclampsia | 25% | 36% | ↑ 11 | 57% | 71% | ↑ 14 | 87% | 90% | ↑ 3 |